Fermand JP, Brouet JC, Danon F, Seligmann M. Gamma heavy chain “disease”: heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature. Medicine (Baltimore) 1989;68:321–35.CrossrefPubMedGoogle Scholar
Kaleta E, Kyle R, Clark R, Katzmann J. Analysis of patients with γ-heavy chain disease by the heavy/light chain and free light chain assays. Clin Chem Lab Med 2014;52(5):665–9.PubMedWeb of ScienceGoogle Scholar
Johannis W, Blommer J, Klatt AR, Renno JH, Wielckens K. Gamma heavy chain disease in a patient with rheumatoid arthritis – a laboratory evaluation. Biochem Med (Zagreb) 2012;22:373–9.Google Scholar
About the article
Published Online: 2018-01-09
Published in Print: 2018-05-24
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.